Design characteristics of included studies.

DFX, deferoxamine; Con, control; SDR, Sprague–Dawley rats; FR, Fischer 344 rats; CM, C57 mice; M, male; F, female; A, aged; N, normal adult; Y, young; CN, caudate nucleus; BG, basal ganglia; Str, striatum; FL, frontal lobe; phB, phenobarbital; PS, pentobarbital sodium; Iso, isoflurane; CH, chloral hydrate; AV, avertin; T/Z, telazol/xylazine; i.p., intraperitoneal; i.m., intramuscular; Inhal, inhaled; NS, neurological score; BWC, brain water content; NR, not reported; R, random assignment; B, blinding; Q, study quality; C, conlusion “+” indicates a positive conclusion and “-” represents a negative conclusion. Design characteristics of included studies.